EFM
E Fund Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Buy |
10,656
+871
| +9% | +$18.9K | 0.01% | 346 |
|
|
2025
Q1 | $237K | Buy |
+9,785
| New | +$237K | 0.01% | 346 |
|
|
2024
Q3 | – | Sell |
-11,266
| Closed | -$175K | – | 360 |
|
|
2024
Q2 | $175K | Sell |
11,266
-11,737
| -51% | -$182K | 0.01% | 299 |
|
|
2024
Q1 | $367K | Buy |
23,003
+4,090
| +22% | +$65.2K | 0.02% | 246 |
|
|
2023
Q4 | $318K | Sell |
18,913
-7,307
| -28% | -$123K | 0.02% | 222 |
|
|
2023
Q3 | $307K | Sell |
26,220
-12,218
| -32% | -$143K | 0.02% | 203 |
|
|
2023
Q2 | $517K | Buy |
38,438
+12,059
| +46% | +$162K | 0.04% | 111 |
|
|
2023
Q1 | $437K | Buy |
26,379
+565
| +2% | +$9.36K | 0.03% | 141 |
|
|
2022
Q4 | $480K | Sell |
25,814
-2,011
| -7% | -$37.4K | 0.04% | 134 |
|
|
2022
Q3 | $357K | Buy |
27,825
+6,490
| +30% | +$83.3K | 0.03% | 205 |
|
|
2022
Q2 | $150K | Buy |
21,335
+9,721
| +84% | +$68.3K | 0.01% | 310 |
|
|
2022
Q1 | $96K | Buy |
+11,614
| New | +$96K | ﹤0.01% | 316 |
|
|
2021
Q4 | – | Sell |
-10,838
| Closed | -$57K | – | 303 |
|
|
2021
Q3 | $57K | Buy |
+10,838
| New | +$57K | ﹤0.01% | 267 |
|
|
2021
Q1 | $84K | Buy |
+18,138
| New | +$84K | 0.01% | 246 |
|